News

July 2016 – Launch Vic Collaboration

BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch Vic are…

July 2016 – Two new strategies launched

In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future These strategies…

Curtin Medal recognises Institute director’s contributions to medical researc

1st July, 2016 – Professor Doug Hilton, director of the Walter and Eliza Hall Institute, has been awarded The Curtin Medal for Excellence in Medical Research for his outstanding contributions to medical science. The award from The John…

CSIRO and 360BioLabs who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer

Congratulations to to BioMelbourne Network members – CSIRO and 360BioLabs – who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer. This is the first round of the…

‘Holy grail’ of breast cancer prevention in high-risk women may be in sight

June 21st, 2016 Walter and Eliza Hall Institute researchers have discovered that an existing medication could have promise in preventing breast cancer in women carrying a faulty BRCA1 gene. This could mean that women with high genetic risk…

Retiring LBT Innovations CEO Lusia Guthrie Appointed Chair of Clever Culture Systems AG

Adelaide, Australia, 10 June 2016: The co-founder and Chief Executive of Australian laboratory automation company LBT Innovations Limited (LBT), Mrs Lusia Guthrie, has been appointed Chair of Clever Culture Systems AG (CCS) for a 2-year period from June…

Updated clinical trial data on CAVATAK™ tumour targeting and immune-activation presented at the American Society Clinical Oncology (ASCO) Annual Meeting

6 June 2016, Sydney, Australia: Viralytics Limited(ASX: VLA, OTC: VRACY) today announced that it has presented posters updating the results of the ongoing Phase 1 STORM/KEYNOTE 200 and the completed Phase 2 CALM clinical trials of Viralytics’ lead…

Melbourne And Boston Strike New Health Agreements

Premier Daniel Andrews today visited the Boston Children’s Hospital as part of his official US visit, announcing a new partnership with Victoria’s Royal Children’s Hospital in Melbourne.As two of the world’s leading children’s hospitals, the Boston and Royal…

Medical researchers warn Australia will lose scientists if funding is not boosted

The society representing Australian medical researchers says the country is at risk of losing high-value scientists to overseas research organisations unless funding for the sector is further increased.In 2015, 13.73 per cent of grant applications to the Federal Government’s National…

Robotic arm that could give amputees the sensation of touch being tested in Melbourne

A robotic arm that could result in amputees regaining their sense of touch and increased movement is the latest breakthrough for Melbourne researchers trying to develop prosthetic limbs that work “like normal”. Key points: Scientists want to send…

April 2016 – Federal Budget: Scientists Push for More Research Funding

Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest in long-term…

Home

News & opinion

Member Directory

Events